Biotech News
Related news
LUNGPulmonx2026-07-29 20:05 EST
Pulmonx Reports Second Quarter 2026 Financial Results
LUNGPulmonx2026-07-28 20:05 EST
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
DCTHDelcath Systems2026-07-16 20:01 EST
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PLSEPulse Biosciences2026-07-15 20:05 EST
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INSMInsmed2026-06-04 11:00 EST
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
STIMNeuronetics2026-07-31 21:00 EST
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
OMOutset Medical2026-07-02 20:05 EST
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
RXSTRxSight2026-07-26 20:00 EST
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Pulmonx
Minimally Invasive COPD Treatment Pulmonx develops minimally invasive technologies for patients with severe emphysema and chronic obstructive pulmonary disease who remain highly symptomatic despite medical therapy. Zephyr Endobronchial Valve The Zephyr Valve is an implantable bronchoscopic device that occludes selected diseased lung...
Recent company news
LUNGPulmonx2026-07-29 20:05 EST
Pulmonx Reports Second Quarter 2026 Financial Results
LUNGPulmonx2026-07-28 20:05 EST
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
LUNGPulmonx2026-07-15 20:05 EST
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
LUNGPulmonx2026-06-01 20:05 EST
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LUNGPulmonx2026-04-29 20:05 EST
Pulmonx Reports First Quarter 2026 Financial Results
Stock data
- Close
- 2.05 USD
- Market cap
- 68M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States